Potential Correlation Between Heart Rate Variability With Cardiovascular Risk at Different Stages of Metabolic Syndrome

NCT06305195 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 155

Last updated 2024-03-12

No results posted yet for this study

Summary

The study aims to assess the beat-to-beat Heart rate variability (HRV) in different stages of metabolic diseases, including pre-diabetic and diabetic patients, compared to non-diabetic individuals.

Heart rate variability will be compared for some antidiabetic drugs used in different stages of metabolic diseases and correlated to different metabolic and inflammatory mediators.

Conditions

Interventions

DIAGNOSTIC_TEST

heart rate variability test

First, the patient is required to lie on their back to have a 5-minute continuous ECG recorded, without performing any maneuvers. Following this, deep breath test, Valsalva and stand test are performed.

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • Labiba K. El-Khordagui, Prof. Dr. · Alexandria University

  • Ahmed F. El-Yazbi, Prof. Dr. · Alamein International University and Alexandria University

  • Mohamed I. Sanhoury, Ass. prof. · Alexandria University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-23
Primary Completion
2024-09-01
Completion
2026-10-21

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06305195 on ClinicalTrials.gov